Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-14 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.43 | 3e-10 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |